These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17934989)

  • 1. A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples.
    Abdallah AB; Scheier LM; Inciardi JA; Copeland J; Cottler LB
    Subst Use Misuse; 2007; 42(11):1651-84. PubMed ID: 17934989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers.
    Sumnall HR; Tyler E; Wagstaff GF; Cole JC
    Drug Alcohol Depend; 2004 Oct; 76(1):93-9. PubMed ID: 15380293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex, touch, and HIV risk among ecstasy users.
    Theall KP; Elifson KW; Sterk CE
    AIDS Behav; 2006 Mar; 10(2):169-78. PubMed ID: 16456728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Goudie AJ; Sumnall HR; Field M; Clayton H; Cole JC
    Drug Alcohol Depend; 2007 Jul; 89(2-3):107-15. PubMed ID: 17254719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
    Matthews A; Bruno R; Johnston J; Black E; Degenhardt L; Dunn M
    Drug Alcohol Depend; 2009 Feb; 100(1-2):24-31. PubMed ID: 19013726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of peers in the initiation and continuation of ecstasy use.
    Vervaeke HK; van Deursen L; Korf DJ
    Subst Use Misuse; 2008; 43(5):633-46. PubMed ID: 18393081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing probability and non-probability sampling methods in Ecstasy research: implications for the internet as a research tool.
    Miller PG; Johnston J; Dunn M; Fry CL; Degenhardt L
    Subst Use Misuse; 2010 Feb; 45(3):437-50. PubMed ID: 20141457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and benefit perceptions of party drug use.
    White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
    Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
    Sumnall HR; Cole JC
    J Psychopharmacol; 2005 Jan; 19(1):84-92. PubMed ID: 15671133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents.
    Yen CF; Hsu SY
    J Nerv Ment Dis; 2007 Oct; 195(10):866-9. PubMed ID: 18043529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2006 Sep; 25(5):445-9. PubMed ID: 16939940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.
    Bedi G; Redman J
    J Psychopharmacol; 2006 May; 20(3):432-6. PubMed ID: 16574718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.